Literature DB >> 11752597

Regulation of mitogen-activated protein kinase signaling networks by G protein-coupled receptors.

J S Gutkind1.   

Abstract

The family of receptors that transmit signals through the activation of heterotrimeric GTP-binding proteins (G proteins) constitutes the largest group of cell surface proteins involved in signal transduction. These receptors participate in a broad range of important biological functions and are implicated in a number of disease states. More than half of all drugs currently available influence G protein-coupled receptors (GPCRs). These receptors affect the generation of small molecules that act as intracellular mediators or second messengers, and can regulate a highly interconnected network of biochemical routes controlling the activity of several members of the mitogen-activated protein kinase (MAPK) superfamily. They include extracellular signal-regulated kinase 1 (ERK1) and ERK2 (or p44(MAPK) and p42(MAPK)), c-Jun NH(2)-terminal kinases (JNKs), ERK5 (or BMK), and p38 MAPKs, including p38alpha (or CSBP-1), p38beta, p38gamma (or SAPK3 or ERK6), and p38delta?(or SAPK4). This review will focus on the molecular mechanisms by which GPCRs signal to the nucleus through this intricate network of second messenger-generating systems and MAPK signaling pathways, thereby affecting the expression of genes whose products influence many biological processes, including normal and aberrant cell growth.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11752597     DOI: 10.1126/stke.2000.40.re1

Source DB:  PubMed          Journal:  Sci STKE        ISSN: 1525-8882


  69 in total

1.  Brain region-specific mechanisms for acute morphine-induced mitogen-activated protein kinase modulation and distinct patterns of activation during analgesic tolerance and locomotor sensitization.

Authors:  Shoshana Eitan; Camron D Bryant; Nazli Saliminejad; Yu C Yang; Elroy Vojdani; Duane Keith; Roberto Polakiewicz; Christopher J Evans
Journal:  J Neurosci       Date:  2003-09-10       Impact factor: 6.167

2.  Gαq G proteins modulate MMP-9 gelatinase during remodeling of the murine femoral artery.

Authors:  Yiping Zou; Yuyang Fu; Mark G Davies
Journal:  J Surg Res       Date:  2012-05-08       Impact factor: 2.192

3.  Regulation of ERK1/2 activity by ghrelin-activated growth hormone secretagogue receptor 1A involves a PLC/PKCvarepsilon pathway.

Authors:  Delphine Mousseaux; Lionel Le Gallic; Joanne Ryan; Catherine Oiry; Didier Gagne; Jean-Alain Fehrentz; Jean-Claude Galleyrand; Jean Martinez
Journal:  Br J Pharmacol       Date:  2006-06       Impact factor: 8.739

4.  Signaling through the neuropeptide GPCR PAC₁ induces neuritogenesis via a single linear cAMP- and ERK-dependent pathway using a novel cAMP sensor.

Authors:  Andrew C Emery; Lee E Eiden
Journal:  FASEB J       Date:  2012-04-24       Impact factor: 5.191

5.  Nitric oxide inhibits ghrelin-induced cell proliferation and ERK1/2 activation in GH3 cells.

Authors:  Chunlei Tian; Fei Ye; Lei Wang; Yuanguo Deng; Yuanxun Dong; Xiaodan Wang; Tongjiang Xu; Ting Lei; Xiongwei Wang
Journal:  Endocrine       Date:  2010-10-23       Impact factor: 3.633

Review 6.  G protein betagamma subunits as targets for small molecule therapeutic development.

Authors:  Alan V Smrcka; David M Lehmann; Axel L Dessal
Journal:  Comb Chem High Throughput Screen       Date:  2008-06       Impact factor: 1.339

7.  Regulation of yeast G protein signaling by the kinases that activate the AMPK homolog Snf1.

Authors:  Sarah T Clement; Gauri Dixit; Henrik G Dohlman
Journal:  Sci Signal       Date:  2013-09-03       Impact factor: 8.192

8.  Rapgef2 connects GPCR-mediated cAMP signals to ERK activation in neuronal and endocrine cells.

Authors:  Andrew C Emery; Maribeth V Eiden; Tomris Mustafa; Lee E Eiden
Journal:  Sci Signal       Date:  2013-06-25       Impact factor: 8.192

9.  Activation of extracellular signal-regulated kinase 5 reduces cardiac apoptosis and dysfunction via inhibition of a phosphodiesterase 3A/inducible cAMP early repressor feedback loop.

Authors:  Chen Yan; Bo Ding; Tetsuro Shishido; Chang-Hoon Woo; Seigo Itoh; Kye-Im Jeon; Weimin Liu; Haodong Xu; Carolyn McClain; Carlos A Molina; Burns C Blaxall; Jun-ichi Abe
Journal:  Circ Res       Date:  2007-02-01       Impact factor: 17.367

10.  The kinin system--bradykinin: biological effects and clinical implications. Multiple role of the kinin system--bradykinin.

Authors:  Ch Golias; A Charalabopoulos; D Stagikas; K Charalabopoulos; A Batistatou
Journal:  Hippokratia       Date:  2007-07       Impact factor: 0.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.